BioCryst Pharmaceuticals | Acreedores Comerciales

Precio De Mercado
6.55
Cambio Diario
0.25 3.97%
Mensual
-7.62%
Anual
-27.14%
Q1 Expectativa
4.65




Acreedores Comerciales Cambio Fecha
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
BioCryst Pharmaceuticals USD 5.57M 3.02M 2025-09
Chugai Pharma JPY 127.25B 48.35B 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
DBV Technologies USD 39.82M 972K 2025-09
Enanta Pharmaceuticals USD 1.95M 1.6M 2025-09
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Novavax USD 15.23M 35.37M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09


BioCryst Pharmaceuticals Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.